Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

[ad_1] Moving Forward as a Stronger Company With a Significantly Improved Balance Sheet and Increased Financial Flexibility  David Stetson and Jon Zinman Appointed to New Board of Directors DUBLIN, Nov.…

High Court of Ireland Confirms Mallinckrodt Scheme of Arrangement

[ad_1] Company Expects to Complete Irish Examinership and Emerge from Chapter 11 in Coming Days DUBLIN, Nov. 10, 2023 /PRNewswire/ — Mallinckrodt plc (OTCMKTS: MNKTQ) (in examination under Part 10…

Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan

[ad_1] DUBLIN, Oct. 10, 2023 /PRNewswire/ — Mallinckrodt plc (in examinership) (OTCMKTS: MNKTQ) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced that its Plan of Reorganization (the…

Mallinckrodt Receives Court Approval for “First Day” Motions to Support Ongoing Operations

[ad_1] Continuing to Serve Customers and Deliver High-Quality Therapies to Patients Without Interruption; Vendors and Suppliers to be Paid in Full in the Ordinary Course DUBLIN, Aug. 30, 2023 /PRNewswire/…

Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations

[ad_1] Initiates Voluntary Prepackaged Chapter 11 Proceedings with Overwhelming Support of Key Stakeholders, Including 85%+ of First and Second Lien Debtholders Continuing to Operate Normally, Serve Customers and Deliver High-Quality…

Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan

[ad_1] Agreement Supported by a Substantial Majority of Each of its First and Second Lien Debtholders and Opioid Trust Financial Restructuring Plan to Significantly Reduce Debt, Increase Free Cash Flow Generation,…